Exelixis Inc (EXEL)
33.29
-0.39
(-1.16%)
USD |
NASDAQ |
Dec 20, 16:00
33.29
0.00 (0.00%)
After-Hours: 20:00
Exelixis Profit Margin (Quarterly): 21.87% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 18.95% |
| ADMA Biologics Inc | 29.96% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Pfizer Inc | 25.22% |
| Sarepta Therapeutics Inc | 7.19% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.97% |
| Return on Assets | 16.15% |
| Return on Invested Capital | 20.97% |
| Gross Profit Margin (Quarterly) | 96.79% |
| Operating Margin (Quarterly) | 34.82% |
| Return on Net Operating Assets | 57.32% |